Renata Duchnowska

гражданство: Польша

родной язык: польский язык

языки, на которых говорит или пишет персона: польский язык

род занятий: исследователь

Серия

There is nothing here

Создать новую серию

Произведения

There is nothing here

Создать новое произведение

Статьи 40

Дата

Заголовок

Авторы

2020-02-05

Expression of Female Sex Hormone Receptors, Connective Tissue Growth Factor and HER2 in Gallbladder Cancer

Rafał Pęksa, Renata Duchnowska, Mariola Iliszko
2020-02-03

CheckMate 171: A phase 2 trial of nivolumab in patients with previously treated advanced squamous non-small cell lung cancer, including ECOG PS 2 and elderly populations

Jacek Jassem, Renata Duchnowska, Janusz Milanowski
2018-05-09

Tyrosine kinase inhibitors for brain metastases in HER2-positive breast cancer.

Jacek Jassem, Renata Duchnowska
2018-09-21

Preventing central nervous system metastases in non-small cell lung cancer

Paweł Krawczyk, Marcin Nicos, Dariusz M Kowalski, Kamila Wojas-Krawczyk, Renata Duchnowska
2018-11

Comparison of central laboratory assessments of ER, PR, HER2, and Ki67 by IHC/FISH and the corresponding mRNAs (ESR1, PGR, ERBB2, and MKi67) by RT-qPCR on an automated, broadly deployed diagnostic platform

Jacek Jassem, Wojciech Biernat, Renata Duchnowska
2018-07-13

Reactive astrocytic S1P3 signaling modulates the blood-tumor barrier in brain metastases

Brunilde Gril, Anurag N Paranjape, Wojciech Kloc, Ewa Izycka-Swieszewska, Renata Duchnowska, Rafał Pęksa, Priscilla K Brastianos, Gary T Pauly, Jacek Jassem, Wojciech Biernat, Emily Hua, Naema Nayyar, Emma Dolan, Joel P. Schneider, William Douglas Figg, Sr., Patricia Steeg
2017-10-24

Predictive value of quantitative HER2, HER3 and p95HER2 levels in HER2-positive advanced breast cancer patients treated with lapatinib following progression on trastuzumab.

Jacek Jassem, Christos J Petropoulos, Wojciech Biernat, Anna Kowalczyk, Renata Duchnowska
2017-11-22

Severe acute toxicity following gemcitabine administration: A report of four cases with cytidine deaminase polymorphisms evaluation.

Bartosz Wasąg, Jacek Jassem, Renata Duchnowska
2017-06-01

Body mass index and long-term outcomes in stage III colon cancer patients administered postoperative chemotherapy

Renata Duchnowska
2017-11-06

SCDT-11. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

Renata Duchnowska, Patricia Steeg
2017-11-06

TMIC-19. ASTROCYTIC S1P3 SIGNALING MODULATES BLOOD-TUMOR BARRIER PERMEABILITY IN BRAIN METASTASES

Renata Duchnowska, Patricia Steeg
2016-12-04

An open label phase II study evaluating first-line EGFR tyrosine kinase inhibitor erlotinib in non-small cell lung cancer patients with tumors showing high EGFR gene copy number

Anna Kowalczyk, Magdalena Ratajska, Tomasz Burzykowski, Janusz Limon, Jacek Jassem, Rafal Dziadziuszko, Wojciech Biernat, Renata Duchnowska, Aleksandra Szczesna
2016-01-01

Problems of diagnostic assessment in advanced pancreatic neuroendocrine neoplasm and treatment implications: a case report and literature review

Grzegorz Kamiński, Cezary Szczylik, Renata Duchnowska
2016-09-08

Brain Metastasis Prediction by Transcriptomic Profiling in Triple-Negative Breast Cancer

Michał Jarząb, Małgorzata Kowalska, Aleksandra Pfeifer, A Musolino, Maria Litwiniuk, Sylwia Szabłowska-Siwik, Ewa Kalinka-Warzocha, Wojciech P Olszewski, Tomasz Tyszkiewicz, Dagmara Rusinek, Malgorzata Oczko-Wojciechowska, Jacek Jassem, Wojciech Biernat, Rafał Matkowski, Renata Duchnowska, Jadwiga Zebracka-Gala
2016-05-31

Alterations in Pericyte Subpopulations Are Associated with Elevated Blood-Tumor Barrier Permeability in Experimental Brain Metastasis of Breast Cancer

Wojciech Kloc, Ewa Izycka-Swieszewska, Priscilla K Brastianos, Renata Duchnowska, Emily Hua, Naema Nayyar, Paul R Lockman, Patricia Steeg
2016-04-27

Immune response in breast cancer brain metastases and their microenvironment: the role of the PD-1/PD-L axis

Wojciech P Olszewski, Anna Kowalczyk, Ewa Kalinka-Warzocha, Tomasz Trojanowski, Sherene Loi, Jacek Jassem, Wojciech Biernat, Rafał Pęksa, Tomasz Mandat, Renata Duchnowska, Bożena Jarosz
2015-01-06

Predicting early brain metastases based on clinicopathological factors and gene expression analysis in advanced HER2-positive breast cancer patients

Yesim Gokmen-Polar, Konrad Wojdan, Jacek Jassem, Wojciech Biernat, George Sledge, Renata Duchnowska, Patricia Steeg
2015-06-11

Immunohistochemical Predictors of Bone Metastases in Breast Cancer Patients

Hanna Majewska, Jacek Jassem, Wojciech Biernat, Rafał Pęksa, Renata Duchnowska
2015-02-13

Quantitative HER2 and p95HER2 levels in primary breast cancers and matched brain metastases

Tomasz Trojanowski, Anna Kowalczyk, Ewa Kalinka-Warzocha, Jacek Jassem, Wojciech Biernat, Tomasz Mandat, Renata Duchnowska, Bożena Jarosz
2015-07-08

Multicentre, Prospective Observational Study of Pegfilgrastim Primary Prophylaxis in Patients at High Risk of Febrile Neutropenia in Poland: PROFIL Study

Wojciech Jurczak, Ewa Kalinka-Warzocha, Renata Duchnowska
2015-11-24

Immunohistochemical prediction of lapatinib efficacy in advanced HER2-positive breast cancer patients

Jacek Jassem, Wojciech Biernat, Anna Kowalczyk, Piotr Jan Wysocki, Renata Duchnowska, Anna Niwińska
2014-06-19

DNA double-strand break repair genes and oxidative damage in brain metastasis of breast cancer

Yesim Gokmen-Polar, Tomasz Trojanowski, Jacek Jassem, Wojciech Biernat, George Sledge, Tomasz Mandat, Renata Duchnowska, Patricia Steeg
2014-06-25

Recurrent pyoderma gangrenosum precipitated by breast cancer: a case report and review of the literature

Renata Duchnowska
2014-03-14

Profound prevention of experimental brain metastases of breast cancer by temozolomide in an MGMT-dependent manner

Stephen M. Hewitt, Jacek Jassem, Wojciech Biernat, Renata Duchnowska, Patricia Steeg
2014-12-01

Metastasis-Initiating Cells in Renal Cancer.

Mohammed Imran Khan, Anna M Czarnecka, Wojciech Kukwa, Cezary Szczylik, Renata Duchnowska
2014-03-25

Quantitative measurements of tumoral p95HER2 protein expression in metastatic breast cancer patients treated with trastuzumab: independent validation of the p95HER2 clinical cutoff.

Jacek Jassem, Wojciech Biernat, Maria Litwiniuk, Piotr Jan Wysocki, Renata Duchnowska
2014-11-06

Badania kontrolne po leczeniu w najczęstszych nowotworach litych u dorosłych

Radosław Mądry, Piotr Jan Wysocki, Maciej Krzakowski, Janusz Siebert, Jacek Jassem, Piotr Rutkowski, Renata Duchnowska
2013-09-20

Immunohistochemical prediction of brain metastases in patients with advanced breast cancer: the role of Rad51.

Jacek Jassem, Wojciech Biernat, Rafał Pęksa, Renata Duchnowska
2013-06-01

Correlation Between Quantitative HER-2 Protein Expression and Risk for Brain Metastases in HER-2+ Advanced Breast Cancer Patients Receiving Trastuzumab-Containing Therapy

Maria Litwiniuk, Jacek Jassem, Wojciech Biernat, Renata Duchnowska
2012-01-10

Correlation between quantitative HER-2 protein expression and risk for brain metastases in HER-2+ advanced breast cancer patients receiving trastuzumab-containing therapy

Marc Buyse, Jacek Jassem, Maria Litwiniuk, Wojciech Biernat, Piotr Jan Wysocki, Renata Duchnowska
2012-08-16

Conversion of epidermal growth factor receptor 2 and hormone receptor expression in breast cancer metastases to the brain

Rafal Dziadziuszko, Tomasz Trojanowski, Wojciech P Olszewski, Anna Kowalczyk, Jacek Jassem, Wojciech Biernat, Janusz Limon, Tomasz Mandat, Renata Duchnowska, Bożena Jarosz
2012-08-08

Trial design on prophylaxis and treatment of brain metastases: lessons learned from the EORTC Brain Metastases Strategic Meeting 2012.

Sven Haller, Jörg-Christian Tonn, Matthias Preusser, Dirk Schadendorf, Jacek Jassem, Jaap C Reijneveld, Martin Klein, Renata Duchnowska, Riccardo Soffietti, Nancy U Lin

Human - wd:Q90133039

Добро пожаловать в Inventaire

the library of your friends and communities

узнать больше